Heikki Joensuu

25PUBLICATIONS
177CO-AUTHORS
Radiation therapyMolecular targetsBiomaterialsSolid tumoursGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 24, 2025
Predictive factors of oral mucositis in patients with locally recurrent inoperable head and neck cancer treated with boron neutron capture therapy.

Tanja Mälkiä, Hanna Koivunoro, Tiina Seppälä

|Jun 27, 2025
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy.

Dong Hu, Xiaoshuang Lyu, Zheqi Li

|May 28, 2025
Integrating Biochemical and Computational Approaches Reveal Structural Insights in Trastuzumab scFv-Fc Antibody Engineering.

Olga Bednova, Jessica Pougoue Ketchemen, Hazem Mslati

|May 20, 2025
Navigating Ongoing Challenges in GI Stromal Tumors.

Heikki Joensuu, Hirotaka Miyashita, Suzanne George

|Apr 25, 2025
Novel Genetic Risk Variants Associated with Oral Tongue Squamous Cell Carcinoma.

Rayan Nikkilä, Antti Mäkitie, Heikki Joensuu

|Mar 26, 2025
Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trial.

Desmond Yip, John Zalcberg, Jean-Yves Blay

Pageof 5

Frequent Collaborators

4 joint publications

Harri Sihto

3 joint publications

Pirkko-Liisa Kellokumpu-Lehtinen

3 joint publications

Sebastian Bauer

2 joint publications

Peter Hohenberger